GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Net Margin %

OrbusNeich Medical Group Holdings (FRA:Q8T) Net Margin % : 23.92% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. OrbusNeich Medical Group Holdings's Net Income for the six months ended in Jun. 2024 was €17.5 Mil. OrbusNeich Medical Group Holdings's Revenue for the six months ended in Jun. 2024 was €73.3 Mil. Therefore, OrbusNeich Medical Group Holdings's net margin for the quarter that ended in Jun. 2024 was 23.92%.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's Net Margin % or its related term are showing as below:

FRA:Q8T' s Net Margin % Range Over the Past 10 Years
Min: -3.82   Med: 7.99   Max: 29.29
Current: 24.23


FRA:Q8T's Net Margin % is ranked better than
91.95% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 0.11 vs FRA:Q8T: 24.23

OrbusNeich Medical Group Holdings Net Margin % Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Net Margin % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial 7.99 -3.82 13.51 29.29 24.20

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.38 30.93 27.45 23.92 24.52

Competitive Comparison of OrbusNeich Medical Group Holdings's Net Margin %

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's Net Margin % falls into.



OrbusNeich Medical Group Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

OrbusNeich Medical Group Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=41.332/141.094
=29.29 %

OrbusNeich Medical Group Holdings's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=17.533/73.307
=23.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrbusNeich Medical Group Holdings  (FRA:Q8T) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


OrbusNeich Medical Group Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines